APA

Singhal M., Gengenbacher N., La Porta S., Gehrs S., Shi J., Kamiyama M., Bodenmiller D. M., Fischl A., Schieb B., Besemfelder E., Chintharlapalli S. & Augustin H. G. (20210818). Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. : EMBO molecular medicine.

Chicago

Singhal Mahak, Gengenbacher Nicolas, La Porta Silvia, Gehrs Stephanie, Shi Jingjing, Kamiyama Miki, Bodenmiller Diane M, Fischl Anthony, Schieb Benjamin, Besemfelder Eva, Chintharlapalli Sudhakar and Augustin Hellmut G. 20210818. Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. : EMBO molecular medicine.

Harvard

Singhal M., Gengenbacher N., La Porta S., Gehrs S., Shi J., Kamiyama M., Bodenmiller D. M., Fischl A., Schieb B., Besemfelder E., Chintharlapalli S. and Augustin H. G. (20210818). Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. : EMBO molecular medicine.

MLA

Singhal Mahak, Gengenbacher Nicolas, La Porta Silvia, Gehrs Stephanie, Shi Jingjing, Kamiyama Miki, Bodenmiller Diane M, Fischl Anthony, Schieb Benjamin, Besemfelder Eva, Chintharlapalli Sudhakar and Augustin Hellmut G. Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. : EMBO molecular medicine. 20210818.